NCT00159497

Brief Summary

This study was designed to investigate the influence of HA-coating on bone remodeling around the cup in cementless THA. 100 patients gave informed consent to participate in a controlled randomized study between porous coated Trilogy® versus Trilogy Calcicoat®. The cup was inserted in press-fit fixation. The femoral component was a cementless porous coated titanium alloy stem (Bi-Metric®), with a modular 28 mm CrCo head. Effect parameters were Harris Hip Score (HHS) and Bone Mineral Density (BMD) determined by DEXA scanning. Measurements revealed no difference between the two groups after 3 years, neither in clinical outcome nor in terms of periprosthetic bone density. Patients with Body Mass Index above normal regained more bone mineral than patients with normal weight. This finding supports the assumption that load is beneficial to bone remodeling. Advantages of better sealing of the bone-prosthesis interface, preventing polyethylene induced osteolysis, may still be anticipated for the 7 or 12 year follow-up examinations

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Oct 1998

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 1998

Completed
6.9 years until next milestone

First Submitted

Initial submission to the registry

September 9, 2005

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 12, 2005

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2011

Completed
Last Updated

March 31, 2014

Status Verified

March 1, 2014

Enrollment Period

12.3 years

First QC Date

September 9, 2005

Last Update Submit

March 28, 2014

Conditions

Keywords

THA

Outcome Measures

Primary Outcomes (1)

  • Changes in bone mineral density around the hip prosthesis, measured by DEXA scanning

    8-12 years

Secondary Outcomes (1)

  • Changes in hip performance, measured by Harris Hip Score

    8-12 years

Study Arms (2)

1

ACTIVE COMPARATOR

Standard porouscoated Trilogy Cup

Device: porous coated Trilogy®

2

EXPERIMENTAL

HA coated Trilogy cup

Device: Trilogy Calcicoat®

Interventions

THA

Also known as: Zimmer
1

THA

Also known as: Zimmer
2

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients eligible for cementless THA

You may not qualify if:

  • Medical conditions interfering with bone metabolism

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northern Orthopaedic Division, Klinik Farsoe, Aalborg University Hospital

Farsø, Northern Jutland, Denmark

Location

Related Links

MeSH Terms

Conditions

Osteoarthritis, Hip

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Mogens B Laursen, MD

    Northern Orthopaedic Division

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 9, 2005

First Posted

September 12, 2005

Study Start

October 1, 1998

Primary Completion

January 1, 2011

Study Completion

January 1, 2011

Last Updated

March 31, 2014

Record last verified: 2014-03

Locations